OKUR: OnKure Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 39.91
Enterprise Value ($M) 64.96
Book Value ($M) 103.83
Book Value / Share 8.14
Price / Book 0.38
NCAV ($M) 101.92
NCAV / Share 7.99
Price / NCAV 0.39

Profitability (mra)
Return on Invested Capital (ROIC) -0.47
Return on Assets (ROA) -2.15
Return on Equity (ROE) -2.84

Liquidity (mrq)
Quick Ratio 10.73
Current Ratio 10.73

Balance Sheet (mrq) ($M)
Current Assets 113.00
Assets 114.91
Liabilities 11.08
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -54.39
Net Income -52.67

Cash Flow Statement (mra) ($M)
Cash From Operations -51.12
Cash from Investing 15.87
Cash from Financing 116.13

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G/A Deep Track Capital, LP 4.14 -20.62
02-07 13G/A Highbridge Capital Management Llc 3.20
02-06 13G/A Lundbeckfond Invest A/S 1.60
01-31 13G Vanguard Group Inc 5.58
11-14 13G/A Tang Capital Management Llc 2.30
10-28 13G/A Octagon Capital Advisors LP 1.80
10-16 13G/A Cormorant Asset Management, LP 14.52
10-11 13G Samsara BioCapital, L.P. 6.50
10-11 13G Citadel Advisors Llc 9.90
10-10 13G Perceptive Advisors Llc 7.90
10-10 13D/A Carlyle Group Inc. 2.20
10-09 13G Acorn Bioventures, L.p. 11.40

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-07 40,534 211,158 19.20
2025-04-04 9,500 309,175 3.07
2025-04-03 1,449 12,076 12.00
2025-04-02 703 13,601 5.17

(click for more detail)

Similar Companies
NTLA – Intellia Therapeutics, Inc. OCS – Oculis Holding AG
OCUL – Ocular Therapeutix, Inc. OMER – Omeros Corporation
PAHC – Phibro Animal Health Corporation


Financial data and stock pages provided by
Fintel.io